| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | C-C motif chemokine 2|HC11|Monocyte chemoattractant protein 1|Monocyte chemotactic and activating factor|MCAF|Monocyte chemotactic protein 1|MCP-1|Monocyte secretory protein JE|Small-inducible cytokine A2|CCL2|MCP1|SCYA2 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse MCP-1 (Monocyte Chemotactic Protein 1) is a molecular target commonly studied in immunology, signal transduction, and neuroscience research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of MCP-1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of MCP-1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
MCP-1 (Monocyte Chemotactic Protein 1) may also be referenced as C-C motif chemokine 2, HC11, and Monocyte chemoattractant protein 1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how MCP-1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, signal transduction, and neuroscience research.
- Interpreting shifts in MCP-1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
MCP-1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, signal transduction, and neuroscience studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Silk-engineered bioactive nanoparticles for targeted alleviation of acute inflammatory disease via macrophage reprogramming
IF: 10.6 Journal: Journal of Nanobiotechnology Author: Integrative Science Center of Germplasm Creation in Western China (Chongqing) Science City, Biological Science Research Center, Southwest University, Chongqing, 400715, China. Cited Date: 2025-01-17
Omega-3 PUFAs Slow Organ Aging through Promoting Energy Metabolism
IF: 9.1 Journal: Pharmacological Research Author: State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangdong Provincial Clinical Research Center for Kidney Disease, Guangdong Provincial Key Laboratory of Nephrology, Division of Nephrology, Nanfang Hospi Cited Date: 2024-09-06
Bruceine A ameliorates ulcerative colitis via macrophage polarization: Targeting HSP90-mediated IL-17 signaling and NF-κB activation
IF: 8.3 Journal: Phytomedicine Author: Shenzhen Bao'an Authentic TCM Therapy Hospital, Shenzhen 518101, PR China. Cited Date: 2025-10-17
Clitocybe squamulosa Polysaccharides Ameliorate Dextran Sulfate Sodium-Induced Colitis by Regulating the PI3K/AKt/mTOR Pathway and the Intestinal Flora in Mice
IF: 6.9 Journal: Food Frontiers Author: College of Food Science and Engineering, Shanxi Agricultural University, Taigu, Shanxi, P. R. China Cited Date: 2025-10-24
Mycobacterium vaccae alleviates allergic airway inflammation and airway hyper-responsiveness in asthmatic mice by altering intestinal microbiota
IF: 6.4 Journal: Immunology Author: Department of Emergency, The First Affiliated Hospital of Guangxi Medical University, Nanning, China Cited Date: 2024-02-18
Elevated CCL2 causes Leydig cell malfunction in metabolic syndrome
IF: 6.205 Journal: JCI Insight Cited Date: 2020-11-13
Finerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy
IF: 5.1 Journal: Cells Author: Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China Cited Date: 2025-03-07
Nanophytosomal Gel of (L.) Extract against Psoriasis: Characterisation, In Vitro and In Vivo Biological Activity
IF: 4.6 Journal: Pharmaceuticals Author: ITS College of Pharmacy, Ghaziabad 201206, Uttar Pradesh, India Cited Date: 2024-02-18